Thorand et al. showed in a human population-based cohort study that the elevated serum levels of IL-18 were associated with a significantly increased risk of T2DM and that this association was independent of CRP and IL-6 [83]. This evidence concerns the gene IL18 and type 2 diabetes mellitus.